BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7010287)

  • 1. The effects of angiotensin II, saralasin, and furosemide on inactive renin in the fetal lamb.
    Siegel S; Parkhill T
    Pediatr Res; 1980 Dec; 14(12):1353-5. PubMed ID: 7010287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous angiotensin stimulation of vasopressin in the newborn lamb.
    Siegel SR; Weitzman RE; Fisher DA
    J Clin Invest; 1979 Feb; 63(2):287-93. PubMed ID: 429554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of the renin-angiotensin-aldosterone system in the fetal and newborn lamb.
    Siegel SR; Fisher DA
    Pediatr Res; 1980 Feb; 14(2):99-102. PubMed ID: 6987603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system in the newborn lamb: response to furosemide.
    Siegel SR; Fisher DA
    Pediatr Res; 1977 Jul; 11(7):837-9. PubMed ID: 876706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of angiotensin II blockade and nephrectomy on the renin-angiotensin-aldosterone system in the newborn lamb.
    Siegel SR; Fisher DA
    Pediatr Res; 1979 May; 13(5 Pt 1):603-5. PubMed ID: 471592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryorenin in the newborn human and lamb.
    Siegel SR; Hadeed A; Zelner R; MacPhee R
    Early Hum Dev; 1981 May; 5(2):151-6. PubMed ID: 7018884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma renin and prorenin (inactive renin) in diabetes mellitus: effects of intravenous furosemide.
    Bryer-Ash M; Fraze EB; Luetscher JA
    J Clin Endocrinol Metab; 1988 Feb; 66(2):454-8. PubMed ID: 3276725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic infusion of angiotensin II on renin and blood pressure in the late-gestation fetal sheep.
    Stanley JR; Giammattei CE; Sheikh AU; Green JL; Zehnder T; Rose JC
    Am J Obstet Gynecol; 1997 Apr; 176(4):931-7. PubMed ID: 9125623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of renin-angiotensin system blockade on visceral blood flow during and after thoracic aortic cross-clamping.
    Joob AW; Harman PK; Kaiser DL; Kron IL
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):411-8. PubMed ID: 3005777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of central angiotensin II receptor antagonism on fetal swallowing and cardiovascular activity.
    El-Haddad MA; Chao CR; Sayed AA; El-Haddad H; Ross MG
    Am J Obstet Gynecol; 2001 Oct; 185(4):828-33. PubMed ID: 11641660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of frusemide, saralasin and hypotension on fetal plasma renin activity and on fetal renal function.
    Lumbers ER; Stevens AD
    J Physiol; 1987 Dec; 393():479-90. PubMed ID: 3328781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.
    Wilczynski EA; Osmond DH
    Hypertension; 1983; 5(3):277-85. PubMed ID: 6341216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin II response to the hemodynamic pathology of ovines with ventricular septal defect.
    Boucek MM; Chang R; Synhorst DP
    Circ Res; 1989 Mar; 64(3):524-31. PubMed ID: 2645059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
    Wong PY; Talamo RC; Williams GH; Colman RW
    J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium intake on the reliability of active renin as a measure of the renin-angiotensin system in essential hypertension.
    Hurwitz S; Potter B; Weiss RJ; Jeunemaitre X; Hopkins PN; Hunt SC; Litchfield WR; Williams GH
    Am J Clin Pathol; 2001 Feb; 115(2):304-12. PubMed ID: 11211621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and measurement of plasma prorenin in the rat.
    Ioannou P; Loh AY; Osmond DH
    Can J Physiol Pharmacol; 1991 Sep; 69(9):1331-40. PubMed ID: 1756434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.